Electronic Antibody Detection via Conductive Electrode Gaps

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for analyzing antibody content in samples, such as blood, are limited by low sensitivity, difficulty in detecting single molecules, and require large, fragile optical imaging devices that are not suitable for field or third-world settings, necessitating a compact, high-sensitivity, and high-selectivity antibody detector.

Innovation Solution

A sensing device comprising a pair of electrodes with a gap and attached ligands capable of binding target proteins or antibodies, allowing for direct, label-free electronic detection and quantification of protein/antibody concentrations through electrical signals, using palladium or platinum electrodes and specific ligands like RGD or thiolated-dinitrophenol.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If fluorescently labeled secondary antibodies are used for detection, then antibody content can be analyzed, but sensitivity is low and single molecule detection is difficult

Engineering Contradiction:
Improvedetection sensitivityVSAvoiddetection method complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent replaces optical detection methods with electronic detection. Specifically, it substitutes fluorescent labeling and optical imaging with direct electronic signal detection through conductive electrodes that measure current fluctuations when target molecules bridge the electrode gap, achieving single molecule detection sensitivity without optical complexity

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent extracts and eliminates the fluorescent labeling step from the detection process. By using conductive target molecules or conductive electrode configurations, the method achieves direct electronic detection without requiring fluorescent tags, thereby simplifying the detection protocol while maintaining or improving sensitivity

Inventive Principle:
Principle #2Taking out (Extraction)

2Measurement precision

If optical imaging devices are used for detection, then antibody analysis is possible, but the devices are large and fragile and not suitable for field deployment

Engineering Contradiction:
Improvedetection capabilityVSAvoidportability and robustness
Core Design Contradiction:
Measurement precisionVSEase of operation

Solution Approach 1:

The patent replaces bulky optical imaging systems with compact electronic detection systems. The use of simple conductive electrodes that measure current fluctuations eliminates the need for complex optical components such as light sources, filters, and cameras, resulting in a portable, robust device suitable for field deployment

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent changes the detection parameter from optical signal (fluorescence intensity) to electrical signal (current fluctuation). This parameter change enables the use of simple, portable electronic measurement equipment instead of complex optical instruments, achieving both portability and detection capability

Inventive Principle:
Principle #35Parameter changes

3Measurement precision

If fluorescent labeling is used for detection, then antibody quantification can be performed, but the contrast is poor

Engineering Contradiction:
Improvedetection contrastVSAvoidlabeling requirement
Core Design Contradiction:
Measurement precisionVSQuantity of substance

Solution Approach 1:

The patent removes the fluorescent labeling requirement entirely by using conductive target molecules or conductive electrode configurations. The detection is based on the inherent electrical properties of the system rather than on fluorescent tags, achieving high contrast through direct electronic signal measurement

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent substitutes optical contrast mechanisms with electronic signal contrast. Instead of relying on fluorescence intensity differences, the method uses current fluctuation patterns that provide superior contrast for detecting and quantifying antibody molecules

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables sensitive and specific detection and quantification of antibodies, including those for Ebola and HPV, with high specificity and sensitivity, suitable for early disease detection and monitoring, even in resource-constrained environments.

Implementation Method 1

protein binding to a ligand can be detected via electronic signals that are induced when the protein is captured by a ligand attached to a closely spaced pair of electrodes

Methodology Applied
Scientific EffectProtein binding to ligand: Adsorption

Data Source

PatentUS12031981B2Method for electronic detection and quantification of antibodies
Publication Date: 2024.07.09 THE ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIV OF ARIZONA
  • US12031981B2 patent drawing
  • US12031981B2 patent drawing
  • US12031981B2 patent drawing

AI summary

The present disclosure relates to a sensing device and methods for detecting, and quantifying the amount of, a target protein in a sample.